Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression

C. Spampinato, E. Aguglia, C. Concerto, M. Pennisi, G. Lanza, R. Bella, M. Cantone, G. Pennisi, I. Kavasidis, D. Giordano

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Major depression is one of the leading causes of disabling condition worldwide and its treatment is often challenging and unsatisfactory, since many patients become refractory to pharmacological therapies. Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological investigation mainly used to study the integrity of the primary motor cortex excitability and of the cortico-spinal tract. The development of paired-pulse and repetitive TMS (rTMS) paradigms has allowed investigators to explore the pathophysiology of depressive disorders and other neuropsychiatric diseases linked to brain excitability dysfunctions. Repetitive transcranial magnetic stimulation has also therapeutic and rehabilitative capabilities since it is able to induce changes in the excitability of inhibitory and excitatory neuronal networks that may persist in time. However, the therapeutic effects of rTMS on major depression have been demonstrated by analyzing only the improvement of neuropsychological performance. The aim of this study was to investigate cortical excitability changes on 12 chronically-medicated depressed patients (test group) after rTMS treatment and to correlate neurophysiological findings to neuropsychological outcomes. In detail, we assessed different parameters of cortical excitability before and after active rTMS in the test group, then compared to those of 10 age-matched depressed patients (control group) who underwent sham rTMS. In line with previous studies, at baseline both groups exhibited a significant interhemispheric difference of motor cortex excitability. This neurophysiological imbalance was then reduced in the patients treated with active rTMS, resulting also in a clinical benefit as demonstrated by the improvement in neuropsychological test scores. On the contrary, after sham rTMS, the interhemispheric difference was still evident in the control group. The reported clinical benefits in the test group might be related to the plastic remodeling of synaptic connection induced by rTMS treatment.

Original languageEnglish
Article number6493451
Pages (from-to)391-403
Number of pages13
JournalIEEE Transactions on Neural Systems and Rehabilitation Engineering
Volume21
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Transcranial Magnetic Stimulation
Motor Cortex
Depression
Pharmaceutical Preparations
Refractory materials
Brain
Plastics
Therapeutics
Control Groups
Neuropsychological Tests
Therapeutic Uses
Depressive Disorder
Research Personnel
Pharmacology
Cortical Excitability

Keywords

  • Biomedical signal processing
  • medical information systems
  • patient rehabilitation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Computer Science Applications
  • Biomedical Engineering
  • Medicine(all)

Cite this

Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression. / Spampinato, C.; Aguglia, E.; Concerto, C.; Pennisi, M.; Lanza, G.; Bella, R.; Cantone, M.; Pennisi, G.; Kavasidis, I.; Giordano, D.

In: IEEE Transactions on Neural Systems and Rehabilitation Engineering, Vol. 21, No. 3, 6493451, 2013, p. 391-403.

Research output: Contribution to journalArticle

Spampinato, C, Aguglia, E, Concerto, C, Pennisi, M, Lanza, G, Bella, R, Cantone, M, Pennisi, G, Kavasidis, I & Giordano, D 2013, 'Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression', IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 21, no. 3, 6493451, pp. 391-403. https://doi.org/10.1109/TNSRE.2013.2256432
Spampinato, C. ; Aguglia, E. ; Concerto, C. ; Pennisi, M. ; Lanza, G. ; Bella, R. ; Cantone, M. ; Pennisi, G. ; Kavasidis, I. ; Giordano, D. / Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression. In: IEEE Transactions on Neural Systems and Rehabilitation Engineering. 2013 ; Vol. 21, No. 3. pp. 391-403.
@article{dc36b8393acb44baa082a428a9dffbe5,
title = "Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression",
abstract = "Major depression is one of the leading causes of disabling condition worldwide and its treatment is often challenging and unsatisfactory, since many patients become refractory to pharmacological therapies. Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological investigation mainly used to study the integrity of the primary motor cortex excitability and of the cortico-spinal tract. The development of paired-pulse and repetitive TMS (rTMS) paradigms has allowed investigators to explore the pathophysiology of depressive disorders and other neuropsychiatric diseases linked to brain excitability dysfunctions. Repetitive transcranial magnetic stimulation has also therapeutic and rehabilitative capabilities since it is able to induce changes in the excitability of inhibitory and excitatory neuronal networks that may persist in time. However, the therapeutic effects of rTMS on major depression have been demonstrated by analyzing only the improvement of neuropsychological performance. The aim of this study was to investigate cortical excitability changes on 12 chronically-medicated depressed patients (test group) after rTMS treatment and to correlate neurophysiological findings to neuropsychological outcomes. In detail, we assessed different parameters of cortical excitability before and after active rTMS in the test group, then compared to those of 10 age-matched depressed patients (control group) who underwent sham rTMS. In line with previous studies, at baseline both groups exhibited a significant interhemispheric difference of motor cortex excitability. This neurophysiological imbalance was then reduced in the patients treated with active rTMS, resulting also in a clinical benefit as demonstrated by the improvement in neuropsychological test scores. On the contrary, after sham rTMS, the interhemispheric difference was still evident in the control group. The reported clinical benefits in the test group might be related to the plastic remodeling of synaptic connection induced by rTMS treatment.",
keywords = "Biomedical signal processing, medical information systems, patient rehabilitation",
author = "C. Spampinato and E. Aguglia and C. Concerto and M. Pennisi and G. Lanza and R. Bella and M. Cantone and G. Pennisi and I. Kavasidis and D. Giordano",
year = "2013",
doi = "10.1109/TNSRE.2013.2256432",
language = "English",
volume = "21",
pages = "391--403",
journal = "IEEE Transactions on Neural Systems and Rehabilitation Engineering",
issn = "1534-4320",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
number = "3",

}

TY - JOUR

T1 - Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drug-resistant major depression

AU - Spampinato, C.

AU - Aguglia, E.

AU - Concerto, C.

AU - Pennisi, M.

AU - Lanza, G.

AU - Bella, R.

AU - Cantone, M.

AU - Pennisi, G.

AU - Kavasidis, I.

AU - Giordano, D.

PY - 2013

Y1 - 2013

N2 - Major depression is one of the leading causes of disabling condition worldwide and its treatment is often challenging and unsatisfactory, since many patients become refractory to pharmacological therapies. Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological investigation mainly used to study the integrity of the primary motor cortex excitability and of the cortico-spinal tract. The development of paired-pulse and repetitive TMS (rTMS) paradigms has allowed investigators to explore the pathophysiology of depressive disorders and other neuropsychiatric diseases linked to brain excitability dysfunctions. Repetitive transcranial magnetic stimulation has also therapeutic and rehabilitative capabilities since it is able to induce changes in the excitability of inhibitory and excitatory neuronal networks that may persist in time. However, the therapeutic effects of rTMS on major depression have been demonstrated by analyzing only the improvement of neuropsychological performance. The aim of this study was to investigate cortical excitability changes on 12 chronically-medicated depressed patients (test group) after rTMS treatment and to correlate neurophysiological findings to neuropsychological outcomes. In detail, we assessed different parameters of cortical excitability before and after active rTMS in the test group, then compared to those of 10 age-matched depressed patients (control group) who underwent sham rTMS. In line with previous studies, at baseline both groups exhibited a significant interhemispheric difference of motor cortex excitability. This neurophysiological imbalance was then reduced in the patients treated with active rTMS, resulting also in a clinical benefit as demonstrated by the improvement in neuropsychological test scores. On the contrary, after sham rTMS, the interhemispheric difference was still evident in the control group. The reported clinical benefits in the test group might be related to the plastic remodeling of synaptic connection induced by rTMS treatment.

AB - Major depression is one of the leading causes of disabling condition worldwide and its treatment is often challenging and unsatisfactory, since many patients become refractory to pharmacological therapies. Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological investigation mainly used to study the integrity of the primary motor cortex excitability and of the cortico-spinal tract. The development of paired-pulse and repetitive TMS (rTMS) paradigms has allowed investigators to explore the pathophysiology of depressive disorders and other neuropsychiatric diseases linked to brain excitability dysfunctions. Repetitive transcranial magnetic stimulation has also therapeutic and rehabilitative capabilities since it is able to induce changes in the excitability of inhibitory and excitatory neuronal networks that may persist in time. However, the therapeutic effects of rTMS on major depression have been demonstrated by analyzing only the improvement of neuropsychological performance. The aim of this study was to investigate cortical excitability changes on 12 chronically-medicated depressed patients (test group) after rTMS treatment and to correlate neurophysiological findings to neuropsychological outcomes. In detail, we assessed different parameters of cortical excitability before and after active rTMS in the test group, then compared to those of 10 age-matched depressed patients (control group) who underwent sham rTMS. In line with previous studies, at baseline both groups exhibited a significant interhemispheric difference of motor cortex excitability. This neurophysiological imbalance was then reduced in the patients treated with active rTMS, resulting also in a clinical benefit as demonstrated by the improvement in neuropsychological test scores. On the contrary, after sham rTMS, the interhemispheric difference was still evident in the control group. The reported clinical benefits in the test group might be related to the plastic remodeling of synaptic connection induced by rTMS treatment.

KW - Biomedical signal processing

KW - medical information systems

KW - patient rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=84877857774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877857774&partnerID=8YFLogxK

U2 - 10.1109/TNSRE.2013.2256432

DO - 10.1109/TNSRE.2013.2256432

M3 - Article

VL - 21

SP - 391

EP - 403

JO - IEEE Transactions on Neural Systems and Rehabilitation Engineering

JF - IEEE Transactions on Neural Systems and Rehabilitation Engineering

SN - 1534-4320

IS - 3

M1 - 6493451

ER -